English | Español
Patient Daily | Dec 24, 2025

Pfizer signals more deals ahead after Metsera acquisition

Patient Daily | Dec 24, 2025

FDA grants first priority voucher approval to USAntibiotics' Augmentin XR
Patient Daily | Dec 24, 2025

Pfizer expands obesity portfolio with new licensing deal; FDA faces leadership changes
Patient Daily | Dec 24, 2025

FDA approves first gene therapy for Wiskott-Aldrich syndrome
Patient Daily | Dec 24, 2025

Neurosurgeon Russell Lonser’s early gene therapy efforts lead to advances in treating brain disorders
Patient Daily | Dec 24, 2025

Tips offered for selecting a primary care practitioner
Patient Daily | Dec 24, 2025

Penn Medicine works to advance treatments for autoimmune bleeding disorders
Patient Daily | Dec 24, 2025

Baylor College of Medicine expert discusses benefits and risks of youth sports participation

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug